Vimarsana
Biggest News Aggregation in the World

Page 42 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults - Vimarsana News

Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults

Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two doses of either Covishield or Covaxin.

Source: india.com
Market authorisation for Covovax as heterologous booster dose approved by the DCGI - New Delhi Times - Vimarsana News

Market authorisation for Covovax as heterologous booster dose approved by the DCGI - New Delhi Times

According to sources, the Drug Controller General of India (DCGI ) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin The DCGI’s approval came following recommendation by the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO).…

DCGI approves market authorisation for SII's Covid vaccine Covovax as heterologous booster dose - Vimarsana News

DCGI approves market authorisation for SII's Covid vaccine Covovax as heterologous booster dose

"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin," an official source said

DCGI Approves Market Authorisation for SII's COVID-19 Vaccine 'Covovax' As Heterologous Booster Dose - Vimarsana News

DCGI Approves Market Authorisation for SII's COVID-19 Vaccine 'Covovax' As Heterologous Booster Dose

The Drug Controller General of India (DCGI ) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. DCGI Approves Market Authorisation for SII’s COVID-19 Vaccine ‘Covovax’ As Heterologous Booster Dose.

Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults - Vimarsana News

Covid vaccine news: SII's Covovax approved as heterologous booster dose for adults

DCGI has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults.